Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms

Clinical trial NCT01189812 · COMPLETED

Trial details

NCT number: NCT01189812
Sponsor: Columbia Northwest Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Dysthymia Depression Not Otherwise Specified Borderline Personality Disorder

Start date: 2010-03-01
Primary completion: 2011-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.